Mr Chai Chong Low > Dentons Rodyk & Davidson LLP > Singapore, Singapore > Lawyer Profile

Dentons Rodyk & Davidson LLP
80 RAFFLES PLACE
#33-00 UOB PLAZA 1
SINGAPORE 048624
Singapore

Work Department

Litigation & Arbitration Practice Group, Commercial Litigation, Corporate & Investment Disputes Litigation, General Litigation, Intellectual Property & Technology Litigation, Litigation Competition Law.

Position

Low Chai Chong is a senior partner in Dentons Rodyk’s Arbitration and Litigation and Dispute Resolution practices, with a focus on Intellectual Property & Technology litigation.

Since 1987, Chai Chong has appeared in numerous cases before the High Court and the Court of Appeal in Singapore. Several of the cases in which he appeared as counsel have been reported in the law journals and law reports of Singapore and Malaysia, and have been the subject of academic articles.

Chai Chong has appeared as counsel for many multinational corporations in matters involving patents, trademarks, copyright, passing off, and trade secrets. His practice encompasses telecommunication and competition law, two emerging areas which have been increasingly active in recent years.

Some of his most recent high profile cases include high court suits: Towa Corporation v ASM Technology Pte Ltd and another; Rohm & Haas v Nexplanar; Bristol-Myers Squibb Pharma Company vs Novartis (S) Pte Ltd; H. Lundbeck A/S v Apotheca Marketing; Merck & Co Inc v  Novartis (S) Pte Ltd (Montelukast).

Career

Senior Partner, Dentons Rodyk & Davidson LLP (formerly Rodyk & Davidson LLP) (1987 – present)

Languages

English, Mandarin

Memberships

Chairman, Solicitors’ Accounts Rules Committee, The Law Society of Singapore
Member of Singapore Copyright Tribunal (appointed by Minister of Law)

Education

LLB (Hons) National University of Singapore, 1986

Lawyer Rankings

Singapore > Intellectual property: Local firms

Dentons Rodyk & Davidson LLP is very active in patent litigation, particularly in the field of pharmaceutical and electromechanical inventions; its team is currently representing Bristol–Myers Squibb in a patent infringement case against Novartis under the patent linkage regime implemented through the US-Singapore FTA. On the non-contentious side, the practice assists local and international clients with acquiring and protecting trade marks, patents, designs and copyright, as well as with the commercialisation of IP rights through licensing and franchising. Ai Ming Lee is experienced in patent disputes concerning semiconductors, telecoms, pharmaceutical and biotechnology issues. Woon-Chooi Yew, Gilbert Leong,Catherine Lee, Chai Chong Low are other key partners.